Chinagene Tech

company

About

Chinagene Tech is an ophthalmology clinical genetic diagnosis organization

  • 11 - 50

Details

Last Funding Type
Corporate Round
Last Funding Money Raised
¥10M
Industries
Clinical Trials,Enterprise
Founded date
Jan 1, 2016
Number Of Employee
11 - 50
Operating Status
Active

Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in the research and development of clinical genetic diagnosis, prevention and gene therapy for hereditary eye diseases. The company's clinical genetic diagnosis platform for hereditary eye diseases can provide fast, accurate, reliable and professional clinical genetic diagnosis services for hereditary ophthalmology patients.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
¥180M
Chinagene Tech has raised a total of ¥180M in funding over 2 rounds. Their latest funding was raised on Mar 30, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 30, 2022 Series A ¥100M 1 Longqian Capital Detail
Mar 29, 2021 Seed ¥70M 2 Lotus Lake Ventures Detail
Mar 6, 2019 Corporate Round ¥10M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
4
Chinagene Tech is funded by 4 investors. Longqian Capital and Lotus Lake Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Longqian Capital Yes Series A
Lotus Lake Ventures Yes Seed
Longmen Capital Seed
Beijing Shoukai Kaiyang Venture Capital Center Corporate Round